Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.42 - $1.48 $6,107 - $21,520
-14,541 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.06 - $2.68 $12 - $32
12 Added 0.08%
14,541 $17,000
Q4 2021

Feb 14, 2022

BUY
$2.5 - $5.19 $36,322 - $75,405
14,529 New
14,529 $36,000
Q3 2020

Nov 16, 2020

SELL
$11.73 - $16.25 $23.4 Million - $32.4 Million
-1,994,235 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$13.68 - $20.46 $634,806 - $949,425
46,404 Added 2.38%
1,994,235 $32 Million
Q1 2020

May 14, 2020

BUY
$14.83 - $26.72 $20.5 Million - $37 Million
1,383,330 Added 245.05%
1,947,831 $30.2 Million
Q4 2019

Feb 18, 2020

BUY
$9.77 - $24.6 $5.52 Million - $13.9 Million
564,501 New
564,501 $13.9 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.